Introduction Hypertension is one of the most common medical disorders in pregnancy and a major cause of maternal and perinatal morbidity and death. In primates adequate development of the embryo, and later of the fetus, depends on a successful hemomonochorial placentation. Nitric oxide (NO) a low molecular weight mediator, induces vasodilatation, inhibits platelet aggregation, and prevents the adhesion of platelets to endothelial cells. Till date, no data are available regarding gestational hypertension (GH) placenta and no metabolism and related enzyme expression and activity. Objectives The present study aimed to evaluate eNOS and iNOS expression in the placentas of both normal and GH patients, by means of Real-Time quantitative PCR, measure placental nitric oxide and peroxynitrite levels in the same group of subjects, and correlate such findings with HELLP group already published. Methods Fifteen patients with gestational hypertension and thirty healthy pregnant controls comparable for maternal and gestational age were enrolled in the study. Placental tissue was taken immediately after delivery. eNOS and iNOS mRNA levels were evaluated Real-Time quantitative PCR, whereas nitric oxide and peroxynitrite production was measured by a commercially available kit. Results Placental eNOS and iNOS mRNA levels were significantly reduced in GH (2,02-fold reduction and 2,33-fold reduction, respectively) when compared to controls. Conversely, NO and ONOO− production were significantly higher in GH group compared to control group (31.56 ± 4.15 nmol NO/mg prot vs. 23.98 ± 5.14 nmol NO/mg prot and 68.49 ± 8.57 arbitrary fluorescence units vs 17.31 ± 2.25 arbitrary fluorescence units; p < 0, 05). Such results were compared to HELLP group obtained in an already published study. Conclusion As from results herein reported, we can hypothesize that complex mechanisms involving NO pathways cause a placental vasculature damage. However, it is not easy to understand if these changes could be interpreted as causes or consequences of this pathologic state.

Gestational hypertension: A study on placental expression of endothelial and inducible nitric oxide synthase and no metabolism / Mazzanti, Laura; Vignini, Arianna; Nanetti, Laura; Cecati, Monia; Raffaelli, Francesca; Giannubilo, Stefano Raffaele; Emanuelli, Monica; Saccucci, Franca; Tranquilli, Andrea Luigi. - In: PREGNANCY HYPERTENSION. - ISSN 2210-7789. - STAMPA. - 2:(2012), pp. 280-281.

Gestational hypertension: A study on placental expression of endothelial and inducible nitric oxide synthase and no metabolism.

MAZZANTI, LAURA;VIGNINI, Arianna;NANETTI, LAURA;CECATI, Monia;RAFFAELLI, FRANCESCA;GIANNUBILO, Stefano Raffaele;EMANUELLI, Monica;SACCUCCI, FRANCA;TRANQUILLI, Andrea Luigi
2012-01-01

Abstract

Introduction Hypertension is one of the most common medical disorders in pregnancy and a major cause of maternal and perinatal morbidity and death. In primates adequate development of the embryo, and later of the fetus, depends on a successful hemomonochorial placentation. Nitric oxide (NO) a low molecular weight mediator, induces vasodilatation, inhibits platelet aggregation, and prevents the adhesion of platelets to endothelial cells. Till date, no data are available regarding gestational hypertension (GH) placenta and no metabolism and related enzyme expression and activity. Objectives The present study aimed to evaluate eNOS and iNOS expression in the placentas of both normal and GH patients, by means of Real-Time quantitative PCR, measure placental nitric oxide and peroxynitrite levels in the same group of subjects, and correlate such findings with HELLP group already published. Methods Fifteen patients with gestational hypertension and thirty healthy pregnant controls comparable for maternal and gestational age were enrolled in the study. Placental tissue was taken immediately after delivery. eNOS and iNOS mRNA levels were evaluated Real-Time quantitative PCR, whereas nitric oxide and peroxynitrite production was measured by a commercially available kit. Results Placental eNOS and iNOS mRNA levels were significantly reduced in GH (2,02-fold reduction and 2,33-fold reduction, respectively) when compared to controls. Conversely, NO and ONOO− production were significantly higher in GH group compared to control group (31.56 ± 4.15 nmol NO/mg prot vs. 23.98 ± 5.14 nmol NO/mg prot and 68.49 ± 8.57 arbitrary fluorescence units vs 17.31 ± 2.25 arbitrary fluorescence units; p < 0, 05). Such results were compared to HELLP group obtained in an already published study. Conclusion As from results herein reported, we can hypothesize that complex mechanisms involving NO pathways cause a placental vasculature damage. However, it is not easy to understand if these changes could be interpreted as causes or consequences of this pathologic state.
2012
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/79841
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact